Work

Therapeutic potential of metabotropic glutamate receptor 7 modulation in correcting cognitive deficits of schizophrenia

Year: 2026

Type: article

Abstract: is proposed to be a viable therapeutic target to treat cognitive deficits driven by glutamatergic dysfunction in disorders including schizophrenia.

Source: Schizophrenia Research

DOI: 10.1016/j.schres.2026.06.012

Authors: Niki M. Harris, Kimberly M. Holter, Colleen M. Niswender

Institutions: Vanderbilt University, Vanderbilt University Medical Center

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,910

Funders: Vanderbilt University, National Institutes of Health, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke

Awards: Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders, G2777262153, G488929812, G6175029438, G87902941, Impact of Metabotropic Glutamate Receptor Heteromerization on Signaling and Pharmacology, Regulation of metabotropic glutamate receptor activity by protein/protein interactions, Metabotropic glutamate receptor 7 as a potential genetic modifier of cognitive deficits in neurofibromatosis, G928359606, G990641700

OpenAlex ID: W7164994818

FWCI:

Cites: 197

Cited by:

Related to: